Treatment of Scrub Typhus
Doxycycline is the drug of choice for scrub typhus in all patients, including children under 8 years, and should be started immediately when the disease is suspected without waiting for laboratory confirmation. 1
First-Line Treatment Regimen
Adults
- Administer doxycycline 100 mg twice daily (oral or IV) for at least 3 days after fever resolves and until clinical improvement is evident 1
- The minimum treatment duration is 5-7 days 1
- Severe or complicated disease may require longer courses 1
Children
- For children weighing less than 45 kg, give doxycycline 2.2 mg/kg body weight twice daily (oral or IV) 1
- The historical concern about dental staining in children under 8 years should not prevent short-course doxycycline use 1
- Treatment duration follows the same principles as adults: at least 3 days after fever subsides with a minimum 5-7 day course 1
Critical Treatment Principles
Timing is Essential
- Treatment must never be delayed while awaiting laboratory confirmation, as delay can lead to severe disease, long-term sequelae, or death 1
- Patients typically respond within 24-48 hours of appropriate antibiotic therapy 1
- Lack of response within 24-48 hours should prompt consideration of alternative diagnoses 1
Expected Clinical Response
- Fever clearance typically occurs within 21-29 hours of treatment initiation 2
- The disease causes vasculitis through endothelial cell infection, which responds rapidly to appropriate antibiotics 1
- Mortality rates up to 4% have been reported in untreated or delayed treatment cases 1
Alternative Treatment Options
Azithromycin
- A single 500 mg dose of azithromycin is as effective as a 1-week course of doxycycline for mild scrub typhus 2
- This is the recommended alternative for pregnant women and children when doxycycline concerns exist 3, 4
- Cure rates of 100% have been demonstrated with single-dose azithromycin in mild disease 2
Rifampin
- Rifampin 600 mg once daily for 5 days shows equivalent efficacy to doxycycline 5
- This is particularly important in areas with documented doxycycline resistance (parts of northern Thailand) 5, 4
- Rifampin remains effective against doxycycline-resistant strains 5
Important Clinical Caveats
Resistance Considerations
- While doxycycline resistance has been documented in parts of northern Thailand, it remains rare in most endemic areas 4
- In regions with known resistance, rifampin should be considered as first-line therapy 5, 4
Diagnostic Pitfalls
- Do not rely on a single serologic test to confirm or exclude diagnosis 6
- The characteristic eschar (painless necrotic lesion with black crust) is not always present 1
- Early antibiotic therapy can diminish or delay antibody development 6